Replimune Gets Third Try at FDA Approval After Makary Departure

Date:




Experimental melanoma drug was rejected twice because the Food and Drug Administration questioned its study design.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Five killed, 34 injured after bus crashes into six cars in Virginia

Five people were killed and dozens hospitalized after a...

Rapper Twista to perform at free Albuquerque community event on Saturday

ALBUQUERQUE, N.M. (KRQE) – Bernalillo County Commission Chair Adriann Barboa...

Ty Herndon Opens Up About Emotional Bonnie Raitt Moment

Ty Herndon was a guest on Taste of Country...

U.S. and Iran Are Close to a Deal

Plus, a plan to put Trump’s face on a...